1. Home
  2. RIOT vs RYTM Comparison

RIOT vs RYTM Comparison

Compare RIOT & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riot Platforms Inc.

RIOT

Riot Platforms Inc.

HOLD

Current Price

$15.84

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$81.84

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIOT
RYTM
Founded
2000
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.8B
IPO Year
2002
2017

Fundamental Metrics

Financial Performance
Metric
RIOT
RYTM
Price
$15.84
$81.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
14
Target Price
$25.43
$131.14
AVG Volume (30 Days)
16.3M
601.3K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.34
EPS
N/A
N/A
Revenue
$647,435,000.00
N/A
Revenue This Year
N/A
$55.34
Revenue Next Year
$24.12
$86.06
P/E Ratio
N/A
N/A
Revenue Growth
71.89
N/A
52 Week Low
$7.40
$55.31
52 Week High
$23.94
$122.20

Technical Indicators

Market Signals
Indicator
RIOT
RYTM
Relative Strength Index (RSI) 46.73 38.51
Support Level $12.02 $74.50
Resistance Level $19.43 $90.79
Average True Range (ATR) 1.08 3.25
MACD -0.12 -0.12
Stochastic Oscillator 14.10 16.59

Price Performance

Historical Comparison
RIOT
RYTM

About RIOT Riot Platforms Inc.

Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: